Development of a matrix metalloproteinase-2 (MMP-2) biosensing system by integrating an enzyme-mediated color development reaction into a common electronics components setup
- 121 Downloads
Matrix metalloproteinase-2 (MMP-2) is closely related to the proliferation and invasion of various types of cancers. The protease is secreted by malignant tumor cells, thus allowing the enzyme to serve as a biomarker for cancer diagnosis. Methods have been developed to analyze MMP-2 activities; however, their applications to disease diagnosis have not been widely demonstrated yet because of the need for highend analytical equipment and labor-intensive processes. In this study, we developed an MMP-2 activity assay system by integrating an engineered autoinhibited β-lactamase which can be activated by MMP-2 in an optical sensing system consisting of reassembled common electronic components, such as a laser diode, a solar cell, and a multimeter. The autoinhibited β-lactamase was immobilized on a polymeric biosensing channel by a polydopamine coating and self-assembled monolayer methods. In the presence of MMP-2, the immobilized autoinhibited β-lactamase was converted to an active form that hydrolyzed the chromogenic cephalosporin CENTA, thereby changing the substrate color from pale yellow (λmax=340 nm) to highly discernible chrome yellow (λmax=405 nm). By reading the interfered laser-light intensity, we were able to analyze MMP-2 activities precisely both with the samples prepared in a buffer solution and also those in urine. These results suggested that the developed system can be used for the quantitative analysis of enzyme activity related to cancer diagnosis.
KeywordsMatrix metalloproteinase-2 Autoinhibited β-lactamase Optical biosensor
Unable to display preview. Download preview PDF.
- 4.Westermarck, J. & Kähäri, V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB. J. 13, 781–792 (1999).Google Scholar
- 8.Moses, M.A., Wiederschain, D., Loughlin, K.R., Zurakowski, D. & Freeman, M.R. Increased Incidence of Matrix Metalloproteinases in Urine of Cancer Patients. Cancer. Res. 58, 1395–1399 (1998).Google Scholar
- 10.Angelina, D.C., Angela, M., Daniela, T. & Matteo, F. Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients. Oncol. Rep. 24, 3–8 (2010).Google Scholar
- 18.Yang, J. et al. Detection of MMP activity in living cells by a genetically encoded surface-displayed FRET sensor. BBA-Mol. Cell. Res. 1773, 400–407 (2007).Google Scholar
- 25.International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of analytical procedures: Text and Methodology Q2(R1) 2005.Google Scholar
- 26.Laraki, N., Franceschini, N., Roßsolini, G.M., Santucci, P. & Meunier, C. Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-Lactamase IMP-1 Produced by Escherichia coli. Antimicrob. Agents Chemother. 43, 902–906 (1999).Google Scholar